King's College London

Research portal

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

Research output: Contribution to journalReview article

Maria Kyrgiou, Marc Arbyn, Christine Bergeron, F. Xavier Bosch, Joakim Dillner, Mark Jit, Jane Kim, Mario Poljak, Pekka Nieminen, Peter Sasieni, Vesna Kesic, Jack Cuzick, Murat Gultekin

Original languageEnglish
Pages (from-to)510-517
Number of pages8
JournalBritish Journal of Cancer
Volume123
Issue number4
DOIs
Published18 Aug 2020

King's Authors

Abstract

This paper summarises the position of ESGO and EFC on cervical screening based on existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as this offers greater protection against cervical cancer and allows longer screening intervals. Only a dozen of HPV tests are considered as clinically validated for screening. The lower specificity of HPV test dictates the use of triage tests that can select women for colposcopy. Reflex cytology is currently the only well validated triage test; HPV genotyping and p16 immunostaining may be used in the future, although methylation assays and viral load also look promising. A summary of quality assurance benchmarks is provided, and the importance to audit the screening histories of women who developed cancer is noted as a key objective. HPV-based screening is more cost-effective than cytology or cotesting. HPV-based screening should continue in the post-vaccination era. Only a fraction of the female population is vaccinated, and this varies across countries. A major challenge will be to personalise screening frequency according to vaccination status. Still the most important factor for successful prevention by screening is high population coverage and organised screening. Screening with self-sampling to reach under-screened women is promising.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454